Health & Environmental Research Online (HERO)


Print Feedback Export to File
7005215 
Journal Article 
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice 
Le Naour, A; Caldefie-Chezet, F; Vasson, MP; Rossary, A; Koffi, Y; Diab, M; Le Guennec, D; Rouge, S; Aldekwer, S; Goncalves-Mendes, N; Talvas, J; Farges, MC; , 
2020 
Yes 
Cancer Cell International
ISSN: 1475-2867 
BMC 
LONDON 
32699527 
WOS:000553450400004 
BackgroundDespite decades of therapeutic trials, effective diagnosis, many drugs available and numerous studies on breast cancer, it remains the deadliest cancer in women. In order to choose the most appropriate treatment and to understand the prognosis of the patients, breast cancer is divided into different subtypes using a molecular classification. Just as there remains a need to discover new effective therapies, models to test them are also required.MethodsThe EO771 (also named E0771 or EO 771) murine mammary cancer cell line was originally isolated from a spontaneous tumour in C57BL/6 mouse. Although frequently used, this cell line remains poorly characterized. Therefore, the EO771 phenotype was investigated. The phenotype was compared to that of MCF-7 cells, known to be of luminal A subtype and to express estrogen receptors, as well as MDA-MB-231 cells, which are triple negative. Their sensitivity to hormonal treatment was evaluated by viability tests.ResultsThe EO771 were estrogen receptor alpha negative, estrogen receptor beta positive, progesterone receptor positive and ErbB2 positive. This phenotype was associated with a sensitivity to anti-estrogen treatments such as tamoxifen, 4-hydroxy-tamoxifen, endoxifen and fulvestrant.ConclusionsOn account of the numerous results published with the EO771 cell line, it is important to know its classification, to facilitate comparisons with corresponding types of tumours in patients. Transcriptomic and protein analysis of the EO771 cell line classified it within the luminal B subtype. Luminal B cancers correspond to one of the subtypes most frequently encountered in patients and associated with a poor prognosis.